167 related articles for article (PubMed ID: 36809998)
1. Biochemical and pathophysiological improvements in rats with thioacetamide induced-hepatocellular carcinoma using aspirin plus vitamin C.
El Sadda RR; Elshahawy ZR; Saad EA
BMC Cancer; 2023 Feb; 23(1):175. PubMed ID: 36809998
[TBL] [Abstract][Full Text] [Related]
2. Targeting p53/TRAIL/caspase-8 signaling by adiponectin reverses thioacetamide-induced hepatocellular carcinoma in rats.
Nazmy EA; El-Khouly OA; Zaki MMA; Elsherbiny NM; Said E; Al-Gayyar MMH; Salem HA
Environ Toxicol Pharmacol; 2019 Nov; 72():103240. PubMed ID: 31421311
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D potentiates anti-tumor activity of 5-fluorouracil via modulating caspase-3 and TGF-β1 expression in hepatocellular carcinoma-induced in rats.
R Ebrahim A; El-Mesery M; El-Karef A; Eissa LA
Can J Physiol Pharmacol; 2018 Dec; 96(12):1218-1225. PubMed ID: 30205014
[TBL] [Abstract][Full Text] [Related]
4. Chloroquine upregulates TRAIL/TRAILR2 expression and potentiates doxorubicin anti-tumor activity in thioacetamide-induced hepatocellular carcinoma model.
Helmy SA; El-Mesery M; El-Karef A; Eissa LA; El Gayar AM
Chem Biol Interact; 2018 Jan; 279():84-94. PubMed ID: 29133031
[TBL] [Abstract][Full Text] [Related]
5. Dioscin suppresses hepatocellular carcinoma tumor growth by inducing apoptosis and regulation of TP53, BAX, BCL2 and cleaved CASP3.
Zhang G; Zeng X; Zhang R; Liu J; Zhang W; Zhao Y; Zhang X; Wu Z; Tan Y; Wu Y; Du B
Phytomedicine; 2016 Nov; 23(12):1329-1336. PubMed ID: 27765352
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol interferes with N-nitrosodiethylamine-induced hepatocellular carcinoma at early and advanced stages in male Wistar rats.
Rajasekaran D; Elavarasan J; Sivalingam M; Ganapathy E; Kumar A; Kalpana K; Sakthisekaran D
Mol Med Rep; 2011; 4(6):1211-7. PubMed ID: 21850372
[TBL] [Abstract][Full Text] [Related]
7. In-vitro and in-vivo investigation of amygdalin, metformin, and combination of both against doxorubicin on hepatocellular carcinoma.
Mamdouh AM; Khodeer DM; Tantawy MA; Moustafa YM
Life Sci; 2021 Nov; 285():119961. PubMed ID: 34536497
[TBL] [Abstract][Full Text] [Related]
8. Selenium nanoparticles and quercetin suppress thioacetamide-induced hepatocellular carcinoma in rats: Attenuation of inflammation involvement.
Mohamed AA; Zaghloul RA; Abdelghany AM; El Gayar AM
J Biochem Mol Toxicol; 2022 Apr; 36(4):e22989. PubMed ID: 35179263
[TBL] [Abstract][Full Text] [Related]
9. Selenium nanoparticles overcomes sorafenib resistance in thioacetamide induced hepatocellular carcinoma in rats by modulation of mTOR, NF-κB pathways and LncRNA-AF085935/GPC3 axis.
Al-Noshokaty TM; Mesbah NM; Abo-Elmatty DM; Abulsoud AI; Abdel-Hamed AR
Life Sci; 2022 Aug; 303():120675. PubMed ID: 35640776
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of diethylnitrosamine-induced hepatocellular carcinoma in a rat model by combination therapy of diacerein and gold nanoparticles: a histopathological and immunohistochemical study.
Baokbah TAS
J Histotechnol; 2023 Mar; 46(1):5-16. PubMed ID: 36214360
[TBL] [Abstract][Full Text] [Related]
11. Protective role of antioxidants on thioacetamide-induced acute hepatic encephalopathy: biochemical and ultrastructural study.
Mustafa HN; El Awdan SA; Hegazy GA
Tissue Cell; 2013 Oct; 45(5):350-62. PubMed ID: 23876406
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of Celastrol on diethylnitrosamine-induced hepatocellular carcinoma in rats and its mechanisms.
Chang W; He W; Li PP; Song SS; Yuan PF; Lu JT; Wei W
Eur J Pharmacol; 2016 Aug; 784():173-80. PubMed ID: 27181068
[TBL] [Abstract][Full Text] [Related]
13. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract][Full Text] [Related]
14. The important role of ADAM8 in the progression of hepatocellular carcinoma induced by diethylnitrosamine in mice.
Li SQ; Wang DM; Zhu S; Ma Z; Li RF; Xu ZS; Han HM
Hum Exp Toxicol; 2015 Nov; 34(11):1053-72. PubMed ID: 25585999
[TBL] [Abstract][Full Text] [Related]
15. Selective cytotoxic activity and protective effects of sodium ascorbate against hepatocellular carcinoma through its effect on oxidative stress and apoptosis
El-Far YM; Khodir AE; Noor AO; Almasri DM; Bagalagel AA; Diri RM; Kutbi HI; Al-Gayyar MMH
Redox Rep; 2020 Dec; 25(1):17-25. PubMed ID: 32172678
[No Abstract] [Full Text] [Related]
16. Chemopreventive and hepatoprotective effects of Epigallocatechin-gallate against hepatocellular carcinoma: role of heparan sulfate proteoglycans pathway.
Darweish MM; Abbas A; Ebrahim MA; Al-Gayyar MM
J Pharm Pharmacol; 2014 Jul; 66(7):1032-45. PubMed ID: 24611903
[TBL] [Abstract][Full Text] [Related]
17. Cape gooseberry (Physalis peruviana) juice as a modulator agent for hepatocellular carcinoma-linked apoptosis and cell cycle arrest.
Hassan HA; Serag HM; Qadir MS; Ramadan MF
Biomed Pharmacother; 2017 Oct; 94():1129-1137. PubMed ID: 28821164
[TBL] [Abstract][Full Text] [Related]
18. The antitumor activity of a lactosaminated albumin conjugate of doxorubicin in a chemically induced hepatocellular carcinoma rat model compared to sorafenib.
Elsadek B; Mansour A; Saleem T; Warnecke A; Kratz F
Dig Liver Dis; 2017 Feb; 49(2):213-222. PubMed ID: 27825923
[TBL] [Abstract][Full Text] [Related]
19. Anti-drug resistance, anti-inflammation, and anti-proliferation activities mediated by melatonin in doxorubicin-resistant hepatocellular carcinoma: in vitro investigations.
Hamed AR; Yahya SMM; Nabih HK
Naunyn Schmiedebergs Arch Pharmacol; 2023 Jun; 396(6):1117-1128. PubMed ID: 36651944
[TBL] [Abstract][Full Text] [Related]
20. Impact of Mesenchymal Stem Cells and Vitamin D on Transforming Growth Factor Beta Signaling Pathway in Hepatocellular Carcinoma in Rats.
Saad El-Din S; Fouad H; Rashed LA; Mahfouz S; Hussein RE
Asian Pac J Cancer Prev; 2018 Apr; 19(4):905-912. PubMed ID: 29693337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
